...
首页> 外文期刊>MIMS Doctor. >Rhythm Association (EHRA 2019)March 1 /-19 Lisbon, Post! Edoxaban joins league with other NOACs as option during AF ablation
【24h】

Rhythm Association (EHRA 2019)March 1 /-19 Lisbon, Post! Edoxaban joins league with other NOACs as option during AF ablation

机译:节奏协会(EHRA 2019) 3月1/-19里斯本,帖子!选择在房颤消融

获取原文
获取原文并翻译 | 示例
           

摘要

Use of uninterrupted edoxaban during catheter ablation for atrial fibrillation (AF) shows comparable safety and efficacy as uninterrupted vitamin K antagonists (VKAs), according to the ELIMINATE-AF trial presented at EHRA 2019. "Periprocedural stroke or transient ischaemic attack and serious bleeding events represent the most feared complications of AF ablation," said Dr Stefan Hohnloser from Johann Wolfgang Goethe University in Frankfurt, Germany.
机译:使用期间不间断edoxaban导管消融心房纤颤(房颤)显示类似的安全性和有效性不间断维生素K拮抗剂(VKAs),根据ELIMINATE-AF审判在EHRA 2019。“周期性中风或短暂性缺血性攻击和严重出血事件代表了说:“最可怕的并发症房颤消融大学在法兰克福,德国。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号